This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ho WK, Hankey GJ, Eiketboom JW. The incidence of venous thromboembolism: A prospective, community-based study in Perth, Western Australia. Med J Aust. 2008;189(3):144-147. doi:10.5694/j.1326-5377.2008.tb01947.xHoWKHankeyGJEiketboomJW. The incidence of venous thromboembolism: A prospective, community-based study in Perth, Western Australia. . 2008;189(3):144-147. doi:10.5694/j.1326-5377.2008.tb01947.xOpen DOISearch in Google Scholar
Martinez C, Cohen AT, Bamber L, Rietbrock S. Epidemiology of first and recurrent venous thromboembolism: A population-based cohort study in patients without active cancer. Thromb Haemost. 2014;112(2):255-263. doi:10.1160/TH13-09-0793MartinezCCohenATBamberLRietbrockS.Epidemiology of first and recurrent venous thromboembolism: A population-based cohort study in patients without active cancer. . 2014;112(2):255-263. doi:10.1160/TH13-09-0793Open DOISearch in Google Scholar
Australian Commission on Safety and Quality in Health Care. Venous Thromboembolism Prevention Clinical Care Standard. ACSQHC.Australian Commission on Safety and Quality in Health Care. . ACSQHC.Search in Google Scholar
Cushman M. Epidemiology and Risk Factors for Venous Thrombosis. Semin Hematol. 2007;44(2):62-69. doi:10.1053/j.seminhematol.2007.02.004CushmanM.Epidemiology and Risk Factors for Venous Thrombosis. . 2007;44(2):62-69. doi:10.1053/j.seminhematol.2007.02.004Open DOISearch in Google Scholar
Tran HA, Gibbs H, Merriman E, et al. New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism. Med J Aust. 2019;210(5):227-235. doi:10.5694/mja2.50004TranHAGibbsHMerrimanE, New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism. . 2019;210(5):227-235. doi:10.5694/mja2.50004Open DOISearch in Google Scholar
Overview of the treatment of lower extremity deep vein thrombosis (DVT) - UpToDate. https://www.uptodate.com/contents/overview-of-the-treatment-of-lower-extremity-deep-vein-thrombosis-dvt. Accessed September 27, 2020.. https://www.uptodate.com/contents/overview-of-the-treatment-of-lower-extremity-deep-vein-thrombosis-dvt. Accessed September 27, 2020.Search in Google Scholar
Kuipers S, Schreijer AJM, Cannegieter SC, Bü Ller HR, Rosendaal FR, Middeldorp & S. Travel and venous thrombosis: a systematic review. doi:10.1111/j.1365-2796.2007.01867.xKuipersSSchreijerAJMCannegieterSCBü LlerHRRosendaalFRMiddeldorp & S.. doi:10.1111/j.1365-2796.2007.01867.xOpen DOISearch in Google Scholar
Lapostolle F, Surget V, Borron SW, et al. Severe Pulmonary Embolism Associated with Air Travel. N Engl J Med. 2001;345(11):779-783. doi:10.1056/NEJMoa010378LapostolleFSurgetVBorronSW, Severe Pulmonary Embolism Associated with Air Travel. . 2001;345(11):779-783. doi:10.1056/NEJMoa010378Open DOISearch in Google Scholar
Ansell J. A IR T RAVEL AND V ENOUS T HROMBOEMBOLISM — I S THE E VIDENCE I N ? N Engl J Med. 2001;345(11):828-830.AnsellJ.A IR T RAVEL AND V ENOUS T HROMBOEMBOLISM — I S THE E VIDENCE I N ?. 2001;345(11):828-830.10.1056/NEJM200109133451110Search in Google Scholar
Jacobson BF, Münster M, Smith A, et al. The BEST study - A prospective study to compare business class versus economy class air travel as a cause of thrombosis. South African Med J. 2003;93(7):522-528. doi:10.7196/SAMJ.2256JacobsonBFMünsterMSmithA, The BEST study - A prospective study to compare business class versus economy class air travel as a cause of thrombosis. . 2003;93(7):522-528. doi:10.7196/SAMJ.2256Open DOISearch in Google Scholar
O’Keeffe DJ, Baglin TP. Travellers’ thrombosis and economy class syndrome: incidence, aetiology and prevention. Clin Lab Haematol. 2003;25(5):277-281. doi:10.1046/j.1365-2257.2003.00533.xO’KeeffeDJBaglinTP. Travellers’ thrombosis and economy class syndrome: incidence, aetiology and prevention. . 2003;25(5):277-281. doi:10.1046/j.1365-2257.2003.00533.xOpen DOISearch in Google Scholar
Carruthers M, Arguelles AE, Mosovich A. Man in Transit: Biochemical and Physiological Changes During Intercontinental Flights. Lancet. 1976;307(7967):977-981. doi:10.1016/S0140-6736(76)91857-2CarruthersMArguellesAEMosovichA.Man in Transit: Biochemical and Physiological Changes During Intercontinental Flights. . 1976;307(7967):977-981. doi:10.1016/S0140-6736(76)91857-2Open DOISearch in Google Scholar
Kelly J, Hunt BJ, Lewis RR, et al. Dehydration and venous thromboembolism after acute stroke. QJM - Mon J Assoc Physicians. 2004;97(5):293-296. doi:10.1093/qjmed/hch050KellyJHuntBJLewisRR, Dehydration and venous thromboembolism after acute stroke. . 2004;97(5):293-296. doi:10.1093/qjmed/hch050Open DOISearch in Google Scholar
Gunga HC, Frommhold M, Hildebrandt W, Kirsch K, Rocker L. Erythropoietin production during flights with pressurised aircrafts [28]. Lancet. 1996;348(9024):416. doi:10.1016/S0140-6736(05)65047-7GungaHCFrommholdMHildebrandtWKirschKRockerL.Erythropoietin production during flights with pressurised aircrafts [28]. . 1996;348(9024):416. doi:10.1016/S0140-6736(05)65047-7Open DOISearch in Google Scholar
Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus. 2011;9(2):120-138. doi:10.2450/2010.0066-10PrevitaliEBucciarelliPPassamontiSMMartinelliI.Risk factors for venous and arterial thrombosis. . 2011;9(2):120-138. doi:10.2450/2010.0066-10Open DOISearch in Google Scholar
Kuipers S, Venemans-Jellema A, Cannegieter SC, et al. The incidence of venous thromboembolism in commercial airline pilots: A cohort study of 2630 pilots. J Thromb Haemost. 2014;12(8):1260-1265. doi:10.1111/jth.12627KuipersSVenemans-JellemaACannegieterSC, The incidence of venous thromboembolism in commercial airline pilots: A cohort study of 2630 pilots. . 2014;12(8):1260-1265. doi:10.1111/jth.12627Open DOISearch in Google Scholar
Calder KK, Herbert M, Henderson SO. The mortality of untreated pulmonary embolism in emergency department patients. Ann Emerg Med. 2005;45(3):302-310. doi:10.1016/j.annemergmed.2004.10.001CalderKKHerbertMHendersonSO. The mortality of untreated pulmonary embolism in emergency department patients. . 2005;45(3):302-310. doi:10.1016/j.annemergmed.2004.10.001Open DOISearch in Google Scholar
Bělohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013;18(2):129-138.BělohlávekJDytrychVLinhartA.Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. . 2013;18(2):129-138.Search in Google Scholar
Wu AR, Garry J, Labropoulos N. Incidence of pulmonary embolism in patients with isolated calf deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2017;5(2):274-279. doi:10.1016/j.jvsv.2016.09.005WuARGarryJLabropoulosN.Incidence of pulmonary embolism in patients with isolated calf deep vein thrombosis. . 2017;5(2):274-279. doi:10.1016/j.jvsv.2016.09.005Open DOISearch in Google Scholar
The Epidemiology of Venous Thromboembolism in the Community.; 2001..; 2001.Search in Google Scholar
Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353(9162):1386-1389. doi:10.1016/S0140-6736(98)07534-5GoldhaberSZVisaniLDe RosaM.Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). . 1999;353(9162):1386-1389. doi:10.1016/S0140-6736(98)07534-5Open DOISearch in Google Scholar
Kaatz S, Ahmad D, Spyropoulos AC, Schulman S. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: Communication from the SSC of the ISTH. J Thromb Haemost. 2015;13(11):2119-2126. doi:10.1111/jth.13140KaatzSAhmadDSpyropoulosACSchulmanS.Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: Communication from the SSC of the ISTH. . 2015;13(11):2119-2126. doi:10.1111/jth.1314026764429Open DOISearch in Google Scholar
Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692-694. doi:10.1111/j.1538-7836.2005.01204.xSchulmanSKearonC.Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. . 2005;3(4):692-694. doi:10.1111/j.1538-7836.2005.01204.x15842354Open DOISearch in Google Scholar
Agnelli G, Buller HR, Cohen A, et al. Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 2013;368(8):699-708. doi:10.1056/NEJMoa1207541AgnelliGBullerHRCohenA, Apixaban for extended treatment of venous thromboembolism. . 2013;368(8):699-708. doi:10.1056/NEJMoa120754123216615Open DOISearch in Google Scholar
Weitz JI, Lensing AWA, Prins MH, et al. Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N Engl J Med. 2017;376(13):1211-1222. doi:10.1056/NEJMoa1700518WeitzJILensingAWAPrinsMH, Rivaroxaban or aspirin for extended treatment of venous thromboembolism. . 2017;376(13):1211-1222. doi:10.1056/NEJMoa170051828316279Open DOISearch in Google Scholar
Wang KL, Van Es N, Cameron C, Castellucci LA, Büller HR, Carrier M. Extended treatment of venous thromboembolism: A systematic review and network meta-analysis. Heart. 2019;105(7):545-552. doi:10.1136/heartjnl-2018-313617WangKLVanEs NCameronCCastellucciLABüllerHRCarrierM.Extended treatment of venous thromboembolism: A systematic review and network meta-analysis. . 2019;105(7):545-552. doi:10.1136/heartjnl-2018-31361730327391Open DOISearch in Google Scholar
Van Es N, Coppens M, Schulman S, Middeldorp S, Büller HR. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: Evidence from phase 3 trials. Blood. 2014;124(12):1968-1975. doi:10.1182/blood-2014-04-571232Van EsNCoppensMSchulmanSMiddeldorpSBüllerHR. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: Evidence from phase 3 trials. . 2014;124(12):1968-1975. doi:10.1182/blood-2014-04-57123224963045Open DOISearch in Google Scholar
(No Title). https://www.theairlinepilots.com/forumarchive/quic kref/icao/annex1.pdf. Accessed September 27, 2020.Search in Google Scholar
New (Novel) Oral Anticoagulants (NOACs) | Civil Aviation Safety Authority. https://www.casa.gov.au/licences-and-certification/aviation-medicine/new-novel-oral-anticoagulants-noacs. Accessed September 27, 2020.New (Novel) Oral Anticoagulants (NOACs) | Civil Aviation Safety Authority. https://www.casa.gov.au/licences-and-certification/aviation-medicine/new-novel-oral-anticoagulants-noacs. Accessed September 27, 2020Search in Google Scholar
Aviation Authority of New Zealand C. Medical Examiners - Medical Manual - Part 3 - Clinical Aviation Medicine - 3.1.Search in Google Scholar
Deep vein thrombosis, pulmonary embolism and use of warfarin | UK Civil Aviation Authority. https://www.caa.co.uk/Aeromedical-Examiners/Medical-standards/Pilots-(EASA)/Conditions/Haematology/Deep-vein-thrombosis,-pulmonary-embolism-and-use-of-warfarin/. Accessed September 27, 2020.. https://www.caa.co.uk/Aeromedical-Examiners/Medical-standards/Pilots-(EASA)/Conditions/Haematology/Deep-vein-thrombosis,-pulmonary-embolism-and-use-of-warfarin/. Accessed September 27, 2020.Search in Google Scholar